Literature DB >> 27298070

Reason-Giving and Medical Futility: Contrasting Legal and Social Discourse in the United States With the United Kingdom and Ontario, Canada.

Gabriel T Bosslet1, Mary Baker2, Thaddeus M Pope3.   

Abstract

Disputes regarding life-prolonging treatments are stressful for all parties involved. These disagreements are appropriately almost always resolved with intensive communication and negotiation. Those rare cases that are not require a resolution process that ensures fairness and due process. We describe three recent cases from different countries (the United States, United Kingdom, and Ontario, Canada) to qualitatively contrast the legal responses to intractable, policy-level disputes regarding end-of-life care in each of these countries. In so doing, we define the continuum of clinical and social utility among different types of dispute resolution processes and emphasize the importance of public reason-giving in the societal discussion regarding policy-level solutions to end-of-life treatment disputes. We argue that precedential, publicly available, written rulings for these decisions most effectively help to move the social debate forward in a way that is beneficial to clinicians, patients, and citizens. This analysis highlights the lack of such rulings within the United States.
Copyright © 2016 American College of Chest Physicians. Published by Elsevier Inc. All rights reserved.

Entities:  

Keywords:  end-of-life; ethics; law

Mesh:

Year:  2016        PMID: 27298070     DOI: 10.1016/j.chest.2016.05.026

Source DB:  PubMed          Journal:  Chest        ISSN: 0012-3692            Impact factor:   9.410


  2 in total

1.  The Charlie Gard case: British and American approaches to court resolution of disputes over medical decisions.

Authors:  J J Paris; J Ahluwalia; B M Cummings; M P Moreland; D J Wilkinson
Journal:  J Perinatol       Date:  2017-10-19       Impact factor: 2.521

2.  Understanding Experiences of Moral Distress in End-of-Life Care Among US and UK Physician Trainees: a Comparative Qualitative Study.

Authors:  Sarah Rosenwohl-Mack; Daniel Dohan; Thea Matthews; Jason Neil Batten; Elizabeth Dzeng
Journal:  J Gen Intern Med       Date:  2020-10-27       Impact factor: 5.128

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.